Expired Tender Bulgaria ICB TOT Ref. 34141536

Contract notice: Pharmaceutical products Tender - 34141536

Tender notice from Bulgaria, published on 25 Jun 2019.

Executive Summary

The ???? „?-? ?????? ??????????“ ???? has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Bulgaria. This Tender notice was published on 25 Jun 2019 and is scheduled to close on 26 Jul 2019, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 34141536, while the tender notice number is 293420-2019 and Register on the platform.

Key facts

Summary
Contract notice: Pharmaceutical products
TOT Ref. No.
34141536
Document Ref. No.
293420-2019
Country
Bulgaria
Notice type
Tender
Competition
ICB
Publication date
25 Jun 2019
Bid deadline
26 Jul 2019
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Object of the contract
Pharmaceutical products
Description: Contract notice: Pharmaceutical products
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: Lowest price
CPV code: 33600000, 33600000
CPV Description: Pharmaceutical Products
Supply of Medicines Included in the Positive Drug List
The subject of this procurement is: Supply of medications included in the PLL. Separate items - no, the drugs are grouped into 49 groups containing a total of 498 nomenclature units. Kazanlak, 16, Stara Zagorska Street, Hospital Pharmacy
Medicinal Supplies (Pharmaceuticals), incl.in the Positive Drug List. Fitness (suitability) to work - participants must have valid documents attesting to their ability to produce and / or trade in medication; in the event that the applicant also offers medications controlled by the LCNFP, he must also hold a license for the wholesale of narcotic substances. Permissions datafor the manufacture and / or trade of medicaments, incl. and the wholesale license for narcotic substances are reflected in EEDOP - Part IV: "Selection Criteria", "A" - "Fitness"
2. Requirements regarding the economic and financial status of the participants - do not apply. 3. Requirements regarding the technical and professional abilities of the participants - do not apply.Candidates must hold valid documents attesting to their ability to produce and / or market medication.
When placing drugs controlled by the LCNFP, the participant must also hold a license for the wholesale of narcotic substances. and financial condition.
Proceedings description:
Group # 4 - Medications fordigestive system and metabolism
- Group # 5 - Antidiarrheal, anti-inflammatory and intestinal infections,
- Group No. 6 - Medications for the nervous system,
- Group No. 7 - Insulin,
- Group № 8 - Medicines for diabetics, Group № 9 - Vitamins,
- Group № 10 - Mineral supplements,
- Group № 11 - Miscellaneous,
- Group № 12 - Glucose solutions,
- Group № 13 - Transfusion solutions,
- Group № 14 - ParenteralNutrition Products
- Group # 15 - Albumin,
- Group No. 16 - Medications for blood and blood-forming organs,
- Group № 17 - Heparin,
- Group № 18 - anti-anemia,
- Group № 20 - Drugs used in cardiology,
- Group № 21 - Medicines for the cardiovascular system,
- Group № 22 - Antihypertensive drugs,
- Group № 23 - Diuretics,
- Group # 26 - Antimycotics for dermatological use, - Group No 27 - Disinfectants antiseptics, - Group No 28 - Medicinal products for the genitourinary system and hormones,
- Group # 29 - Systemic Corticosteroids,
- Group No. 30 - Thyroid Therapy Products,
- Group No 31 - Antibiotics,
- Group No 32 - Antimycotic- Group No 33 - Anti-inflammatory and anti-rheumatic drugs, - Group No 34 - Medicines for relaxation of muscles, - Group No 35 - Antineoplastic agents and immunomodulators, - Group No 36 - Group № 37 - Pain relievers,
- Group № 38 - Against epilepsy,
- Group № 39 - Against parkinsonism,
- Group №40 - Psycholeptic agents,
- Group №41 - Dogs
- Group №42 - Other drugs for the nervous system,
- Group №43 - Antiprotozoa agents,
- Group №44 - Drugs for the respiratory system,
- Group №45 - Antihistamines for systemic use,
- Group № 46 - Ophthalmic drugs,
- Group №47 - Medicines for cough and runny nose,
- Group №48 - Reagents and contrast agents,
- Group №49 - Immunoseles and immunoglobulins
Assignshall remove from the procedure a participant for whom the grounds under Art. 54, para. 1 and 55, para. 1 of the PPA, which occurred before or during the procedure. The provision applies also when a participant in the procedure is a grouping of natural and / or legal entities and one of the grounds for removal is a member of the grouping.
Internet address (URL): www.mbal-kazanlak.com

Documents

Tender Notice
Login to view

Similar tenders

Bulgaria Public Procurement Intelligence

Frequently asked questions

The bid deadline for Contract notice: Pharmaceutical products was 26 Jul 2019. Bidding is closed.

This tender has been issued by ???? „?-? ?????? ??????????“ ???? in Bulgaria.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 34141536. The purchaser document reference is 293420-2019.

See the Similar Tenders section on this page or browse other tenders from Bulgaria.

This tender falls under Materials and Products in Bulgaria. Suppliers in these sectors can track similar Bulgaria tenders using CPV-based alerts.